Christine Espiritu

Sr. Scientist at Arbutus Biopharma

Christine Espiritu currently works as a Sr. Scientist at Arbutus Biopharma Corporation and has extensive experience in HBV drug discovery. Prior to their current role, Christine has held positions at various prestigious organizations such as Janssen Pharmaceutical R&D, Novira Therapeutics, and Gilead Sciences, where Christine has played key roles in drug development and research. Christine's educational background includes a Master's degree in Biology with a focus on Recombinant DNA Technology from New York University and a Bachelor's degree in Biochemistry from the University of California, Los Angeles.

Location

Highland Park, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Arbutus Biopharma

2 followers

Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).


Industries

Employees

51-200

Links